SCHEMBL8204675

SCHEMBL8204675

O=C(O)C=Cc1ccc2c(c1)CN(C(=O)O)CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.47
HPGD P15428 4/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
HDAC1 Q13547 7/20 0.45
ALDH1A1 P00352 2/20 0.45
POLB P06746 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
KDM4E B2RXH2 4/20 0.44
HTT P42858 2/20 0.44
CYP2C9 P11712 2/20 0.44
MAPK1 P28482 2/20 0.44
LMNA P02545 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
HSD17B10 Q99714 2/20 0.44
HDAC3 O15379 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8204673 1.00 MAPT (0.47) MAPTHPGDRAB9ANPC1HDAC1
SCHEMBL27766220 0.85 KDM4E (0.48) MAPTHPGDHDAC1ALDH1A1MEN1
SCHEMBL8186254 0.84 POLB (0.48) MAPTHPGDRAB9AHDAC1ALDH1A1
SCHEMBL8186252 0.84 POLB (0.48) MAPTHPGDRAB9AHDAC1ALDH1A1
SCHEMBL7968822 0.84 ESR1 (0.44) MAPTHPGDRAB9ANPC1HDAC1
SCHEMBL7974045 0.82 TTR (0.51) MAPTHPGDRAB9ANPC1HDAC1
SCHEMBL8179896 0.82 MMP1 (0.53) RAB9ANPC1HDAC1MEN1KMT2A
SCHEMBL7974049 0.82 TTR (0.51) MAPTHPGDRAB9ANPC1HDAC1
SCHEMBL8179894 0.82 MMP1 (0.53) RAB9ANPC1HDAC1MEN1KMT2A
SCHEMBL20162151 0.80 KDM4E (0.48) MAPTHPGDHDAC1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000007993-A1 SUBSTITUTED ISOQUINOLEINES AND THEIR USE AS ANTICONVULSIVANTS SMITHKLINE BEECHAM PLC (GB) 2000-02-17 WO disclosed